GAA and type 2 diabetes mellitus: Another meta-analysis suggested that alpha-glucosidase inhibitors (alpha-GIs) can attenuate the CIMT progression in patients with impaired glucose tolerance or type 2 diabetes mellitus (T2DM) [10].